OnKure Therapeutics, Inc. Class A Common Stock

OKUR XNAS • PHARMACEUTICAL PREPARATIONS

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

170M

Short interest (May 15)

0.5%

Borrow Fee

1.16%

↓ 6.9%

Available Shares

800K

↑ 4.7%

Price Chart

Company Overview

OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing precision medicines that target biologically validated drivers of cancers underserved by available therapies. The company uses a structure-based drug design platform to develop a pipeline of drug candidates aimed at optimizing efficacy and tolerability. The company has multiple programs focused on targeting oncogenic PI3Kα. Its flagship program is OKI-219. The company operates in one operating segment: clinical research.

Company Info

Exchange: NASDAQ

Industry: PHARMACEUTICAL PREPARATIONS

CIK: 0001637715

Asset Type: CS

Market Data

Market Cap: $170,468,925

Employees: 45

Status: Active

Short Interest

Current Borrow Fee 1.16%

Range: 1.16% - 1.49%

Available Shares 800K

Range: 550K - 750K

Recent Changes

Fee Change: ↓ 15.1%

Available Change: ↑ 19.2%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime